<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36817481</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target.</ArticleTitle><Pagination><StartPage>1103307</StartPage><MedlinePgn>1103307</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1103307</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1103307</ELocationID><Abstract><AbstractText>Age/autoimmunity-associated B cells (ABCs) are a novel B cell subpopulation with a unique transcriptional signature and cell surface phenotype. They are not sensitive to BCR but rely on TLR7 or TLR9 in the context of T cell-derived cytokines for the differentiation. It has been established that aberrant expansion of ABCs is linked to the pathogenesis of systemic autoimmune diseases such as systemic lupus erythematosus. Recently, we and other groups have shown that increased ABCs is associated with rheumatoid arthritis (RA) disease activity and have demonstrated their pathogenic role in RA, indicating that targeting specific B cell subsets is a promising strategy for the treatment of inflammatory arthritis. In this review, we summarize the current knowledge of ABCs, focusing on their emerging role in the pathogenesis of inflammatory arthritis. A deep understanding of the biology of ABCs in the context of inflammatory settings <i>in vivo</i> will ultimately contribute to the development of novel targeted therapies for the treatment of inflammatory arthritis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Li, Cai, Qin and Chen.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhen-Yu</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Ming-Long</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, the First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">age-associated B cells</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">immunopathogenesis</Keyword><Keyword MajorTopicYN="N">inflammatory arthritis</Keyword><Keyword MajorTopicYN="N">therapeutic target</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>9</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36817481</ArticleId><ArticleId IdType="pmc">PMC9933781</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1103307</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barbour KE, Helmick CG, Boring M, Brady TJ. Vital signs: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - united states, 2013-2015. MMWR Morb Mortal Wkly Rep (2017) 66(9):246&#x2013;53. doi: 10.15585/mmwr.mm6609e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6609e1</ArticleId><ArticleId IdType="pmc">PMC5687192</ArticleId><ArticleId IdType="pubmed">28278145</ArticleId></ArticleIdList></Reference><Reference><Citation>Knevel R, le Cessie S, Terao CC, Slowikowski K, Cui J, Huizinga TWJ, et al. . Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci Transl Med (2020) 12(545):eaay1548. doi: 10.1126/scitranslmed.aay1548</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aay1548</ArticleId><ArticleId IdType="pmc">PMC7341896</ArticleId><ArticleId IdType="pubmed">32461333</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. . Rheumatoid arthritis. Nat Rev Dis Primers (2018) 4:18001. doi: 10.1038/nrdp.2018.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.1</ArticleId><ArticleId IdType="pubmed">29417936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol (2022) 18(7):384&#x2013;97. doi: 10.1038/s41584-022-00790-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00790-8</ArticleId><ArticleId IdType="pubmed">35672464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlinton D. B cells still front and centre in immunology. Nat Rev Immunol (2019) 19(2):85&#x2013;6. doi: 10.1038/s41577-018-0107-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0107-2</ArticleId><ArticleId IdType="pubmed">30602730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Jensen PE. The role of b lymphocytes as antigen-presenting cells. Arch Immunol Ther Exp (Warsz) (2008) 56(2):77&#x2013;83. doi: 10.1007/s00005-008-0014-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-008-0014-5</ArticleId><ArticleId IdType="pubmed">18373241</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol (2015) 15(3):160&#x2013;71. doi: 10.1038/nri3795</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3795</ArticleId><ArticleId IdType="pubmed">25698678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser EC, Mauri C. Regulatory b cells: origin, phenotype, and function. Immunity (2015) 42(4):607&#x2013;12. doi: 10.1016/j.immuni.2015.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.04.005</ArticleId><ArticleId IdType="pubmed">25902480</ArticleId></ArticleIdList></Reference><Reference><Citation>Aletaha D, Bluml S. Therapeutic implications of autoantibodies in rheumatoid arthritis. RMD Open (2016) 2(1):e000009. doi: 10.1136/rmdopen-2014-000009</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2014-000009</ArticleId><ArticleId IdType="pmc">PMC4879342</ArticleId><ArticleId IdType="pubmed">27252890</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorarinsdottir K, Camponeschi A, Jonsson C, Granhagen Onnheim K, Nilsson J, Forslind K, et al. . CD21(-/low) b cells associate with joint damage in rheumatoid arthritis patients. Scand J Immunol (2019) 90(2):e12792. doi: 10.1111/sji.12792</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12792</ArticleId><ArticleId IdType="pubmed">31141193</ArticleId></ArticleIdList></Reference><Reference><Citation>Floudas A, Neto N, Marzaioli V, Murray K, Moran B, Monaghan MG, et al. . Pathogenic, glycolytic PD-1+ b cells accumulate in the hypoxic RA joint. JCI Insight (2020) 5(21):e139032. doi: 10.1172/jci.insight.139032</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.139032</ArticleId><ArticleId IdType="pmc">PMC7710281</ArticleId><ArticleId IdType="pubmed">33148884</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. . Efficacy of b-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med (2004) 350(25):2572&#x2013;81. doi: 10.1056/NEJMoa032534</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032534</ArticleId><ArticleId IdType="pubmed">15201414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco KA, Abraham RS. Consequences of b-cell-depleting therapy: hypogammaglobulinemia and impaired b-cell reconstitution. Immunotherapy (2018) 10(8):713&#x2013;28. doi: 10.2217/imt-2017-0178</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt-2017-0178</ArticleId><ArticleId IdType="pubmed">29569510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, O&#x2019;Neill P, Naradikian MS, Scholz JL, Cancro MP. A b-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood (2011) 118(5):1294&#x2013;304. doi: 10.1182/blood-2011-01-330530</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-330530</ArticleId><ArticleId IdType="pmc">PMC3152496</ArticleId><ArticleId IdType="pubmed">21562046</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. . Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ b-cell population is important for the development of autoimmunity. Blood (2011) 118(5):1305&#x2013;15. doi: 10.1182/blood-2011-01-331462</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost C, Arleevskaya MI, Brooks WH, Plaza S, Guery JC, Renaudineau Y. Long non-coding RNA xist contribution in systemic lupus erythematosus and rheumatoid arthritis. Clin Immunol (2022) 236:108937. doi: 10.1016/j.clim.2022.108937</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.108937</ArticleId><ArticleId IdType="pubmed">35114365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, van Dyk LF, Kappler JW, Marrack P. T-Box transcription factor T-bet, a key player in a unique type of b-cell activation essential for effective viral clearance. Proc Natl Acad Sci U S A. (2013) 110(34):E3216&#x2013;24. doi: 10.1073/pnas.1312348110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312348110</ArticleId><ArticleId IdType="pmc">PMC3752276</ArticleId><ArticleId IdType="pubmed">23922396</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett BE, Staupe RP, Odorizzi PM, Palko O, Tomov VT, Mahan AE, et al. . Cutting edge: B cell-intrinsic T-bet expression is required to control chronic viral infection. J Immunol (2016) 197(4):1017&#x2013;22. doi: 10.4049/jimmunol.1500368</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500368</ArticleId><ArticleId IdType="pmc">PMC4975981</ArticleId><ArticleId IdType="pubmed">27430722</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeng-Adjei N, Portugal S, Holla P, Li S, Sohn H, Ambegaonkar A, et al. . Malaria-induced interferon-&#x3b3; drives the expansion of tbethi atypical memory b cells. PloS Pathog (2017) 13(9):e1006576. doi: 10.1371/journal.ppat.1006576</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006576</ArticleId><ArticleId IdType="pmc">PMC5633206</ArticleId><ArticleId IdType="pubmed">28953967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kugler-Umana O, Zhang W, Kuang Y, Liang J, Castonguay CH, Tonkonogy SL, et al. . IgD(+) age-associated b cells are the progenitors of the main T-independent b cell response to infection that generates protective ab and can be induced by an inactivated vaccine in the aged. Aging Cell (2022) 21(10):e13705. doi: 10.1111/acel.13705</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13705</ArticleId><ArticleId IdType="pmc">PMC9577953</ArticleId><ArticleId IdType="pubmed">36056604</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhou S, Qian J, Wang Y, Yu X, Dai D, et al. . T-bet(+)CD11c(+) b cells are critical for antichromatin immunoglobulin G production in the development of lupus. Arthritis Res Ther (2017) 19(1):225. doi: 10.1186/s13075-017-1438-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-017-1438-2</ArticleId><ArticleId IdType="pmc">PMC5629756</ArticleId><ArticleId IdType="pubmed">28982388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. . IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) b cells in SLE. Nat Commun (2018) 9(1):1758. doi:&#xa0;10.1038/s41467-018-03750-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03750-7</ArticleId><ArticleId IdType="pmc">PMC5931508</ArticleId><ArticleId IdType="pubmed">29717110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. . Distinct effector b cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity (2018) 49(4):725&#x2013;39.e6. doi: 10.1016/j.immuni.2018.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadoun D, Terrier B, Bannock J, Vazquez T, Massad C, Kang I, et al. . Expansion of autoreactive unresponsive CD21-/low b cells in sjogren&#x2019;s syndrome-associated lymphoproliferation. Arthritis Rheumatol (2013) 65(4):1085&#x2013;96. doi: 10.1002/art.37828</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37828</ArticleId><ArticleId IdType="pmc">PMC4479193</ArticleId><ArticleId IdType="pubmed">23279883</ArticleId></ArticleIdList></Reference><Reference><Citation>Claes N, Fraussen J, Vanheusden M, Hellings N, Stinissen P, Van Wijmeersch B, et al. . Age-associated b cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients. J Immunol (2016) 197(12):4576&#x2013;83. doi: 10.4049/jimmunol.1502448</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502448</ArticleId><ArticleId IdType="pubmed">27837111</ArticleId></ArticleIdList></Reference><Reference><Citation>Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, et al. . Age-associated b cells appear in patients with granulomatous lung diseases. Am J Respir Crit Care Med (2020) 202(7):1013&#x2013;23. doi: 10.1164/rccm.201911-2151OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201911-2151OC</ArticleId><ArticleId IdType="pmc">PMC7528799</ArticleId><ArticleId IdType="pubmed">32501729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhtiar S, Kaffenberger C, Salzmann-Manrique E, Donhauser S, Lueck L, Karaca NE, et al. . Regulatory b cells in patients suffering from inborn errors of immunity with severe immune dysregulation. J Autoimmun (2022) 132:102891. doi: 10.1016/j.jaut.2022.102891</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102891</ArticleId><ArticleId IdType="pubmed">36113303</ArticleId></ArticleIdList></Reference><Reference><Citation>Guffroy A, Mourot-Cottet R, Gerard L, Gies V, Lagresle C, Pouliet A, et al. . Neutropenia in patients with common variable immunodeficiency: a rare event associated with severe outcome. J Clin Immunol (2017) 37(7):715&#x2013;26. doi: 10.1007/s10875-017-0434-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-017-0434-2</ArticleId><ArticleId IdType="pubmed">28842786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. . Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol (2019) 20(7):928&#x2013;42. doi: 10.1038/s41590-019-0378-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0378-1</ArticleId><ArticleId IdType="pmc">PMC6602051</ArticleId><ArticleId IdType="pubmed">31061532</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Cai ML, Jin HZ, Huang W, Zhu C, Bozec A, et al. . Age-associated b cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-alpha-mediated ERK1/2 and JAK-STAT1 pathways. Ann Rheum Dis (2022) 81(11):1504&#x2013;1514. doi: 10.1136/ard-2022-222605</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-222605</ArticleId><ArticleId IdType="pubmed">35760450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro MP. Age-associated b cells. Annu Rev Immunol (2020) 38:315&#x2013;40. doi: 10.1146/annurev-immunol-092419-031130</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-092419-031130</ArticleId><ArticleId IdType="pubmed">31986068</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wang Z, Wang J, Diao Y, Qian X, Zhu N. T-bet-Expressing b cells are positively associated with crohn&#x2019;s disease activity and support Th1 inflammation. DNA Cell Biol (2016) 35(10):628&#x2013;35. doi: 10.1089/dna.2016.3304</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2016.3304</ArticleId><ArticleId IdType="pubmed">27348235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Zhang H, Liu S, Xia F, Kang Z, Zhang Y, et al. . Excessive CD11c(+)Tbet(+) b cells promote aberrant TFH differentiation and affinity-based germinal center selection in lupus. Proc Natl Acad Sci U S A. (2019) 116(37):18550&#x2013;60. doi: 10.1073/pnas.1901340116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901340116</ArticleId><ArticleId IdType="pmc">PMC6744857</ArticleId><ArticleId IdType="pubmed">31451659</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Blanco A, Dominguez-Pantoja M, Botia-Sanchez M, Perez-Cabrera S, Bello-Iglesias N, Carrillo-Rodriguez P, et al. . CD38 deficiency ameliorates chronic graft-Versus-Host disease murine lupus via a b-Cell-Dependent mechanism. Front Immunol (2021) 12:713697. doi: 10.3389/fimmu.2021.713697</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.713697</ArticleId><ArticleId IdType="pmc">PMC8421681</ArticleId><ArticleId IdType="pubmed">34504495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagglof T, Vanz C, Kumagai A, Dudley E, Ortega V, Siller M, et al. . T-Bet(+) b cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. Cell Metab (2022) 34(8):1121&#x2013;36 e6. doi: 10.1016/j.cmet.2022.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.07.002</ArticleId><ArticleId IdType="pmc">PMC9357106</ArticleId><ArticleId IdType="pubmed">35868310</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox JJ, Buggert M, Kardava L, Seaton KE, Eller MA, Canaday DH, et al. . T-Bet+ b cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight (2017) 2(8):e92943. doi: 10.1172/jci.insight.92943</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92943</ArticleId><ArticleId IdType="pmc">PMC5396521</ArticleId><ArticleId IdType="pubmed">28422752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruschil C, Gabernet G, Lepennetier G, Heumos S, Kaminski M, Hracsko Z, et al. . Specific induction of double negative b cells during protective and pathogenic immune responses. Front Immunol (2020) 11:606338. doi: 10.3389/fimmu.2020.606338</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.606338</ArticleId><ArticleId IdType="pmc">PMC7775384</ArticleId><ArticleId IdType="pubmed">33391273</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstappen GM, Ice JA, Bootsma H, Pringle S, Haacke EA, de Lange K, et al. . Gene expression profiling of epithelium-associated FcRL4(+) b cells in primary sjogren&#x2019;s syndrome reveals a pathogenic signature. J Autoimmun (2020) 109:102439. doi: 10.1016/j.jaut.2020.102439</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102439</ArticleId><ArticleId IdType="pmc">PMC7337041</ArticleId><ArticleId IdType="pubmed">32201227</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrapodi R, Pellicano C, Radicchio G, Leodori G, Colantuono S, Iacolare A, et al. . CD21(low) b cells in systemic sclerosis: A possible marker of vascular complications. Clin Immunol (2020) 213:108364. doi: 10.1016/j.clim.2020.108364</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108364</ArticleId><ArticleId IdType="pubmed">32087329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau D, Lan LY, Andrews SF, Henry C, Rojas KT, Neu KE, et al. . Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation. Sci Immunol (2017) 2(7):eaai8153. doi: 10.1126/sciimmunol.aai8153</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aai8153</ArticleId><ArticleId IdType="pmc">PMC5896567</ArticleId><ArticleId IdType="pubmed">28783670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton CM, Fucile CF, Darce J, Chida A, Ichikawa T, Gregoretti I, et al. . Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol (2015) 16(7):755&#x2013;65. doi: 10.1038/ni.3175</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3175</ArticleId><ArticleId IdType="pmc">PMC4512288</ArticleId><ArticleId IdType="pubmed">26006014</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JL, Rosenthal RL, Knox JJ, Myles A, Naradikian MS, Madej J, et al. . The transcription factor T-bet resolves memory b cell subsets with distinct tissue distributions and antibody specificities in mice and humans. Immunity (2020) 52(5):842&#x2013;55.e6. doi: 10.1016/j.immuni.2020.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.03.020</ArticleId><ArticleId IdType="pmc">PMC7242168</ArticleId><ArticleId IdType="pubmed">32353250</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivedi N, Weisel F, Smita S, Joachim S, Kader M, Radhakrishnan A, et al. . Liver is a generative site for the b cell response to ehrlichia muris. Immunity (2019) 51(6):1088&#x2013;101.e5. doi: 10.1016/j.immuni.2019.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC6955021</ArticleId><ArticleId IdType="pubmed">31732168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CC, Baccarella AM, Bayat A, Pepper M, Fontana MF. FCRL5(+) memory b cells exhibit robust recall responses. Cell Rep (2019) 27(5):1446&#x2013;60.e4. doi: 10.1016/j.celrep.2019.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.04.019</ArticleId><ArticleId IdType="pmc">PMC6530801</ArticleId><ArticleId IdType="pubmed">31042472</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Mazliah D, Gardner PJ, Schweighoffer E, McLaughlin S, Hosking C, Tumwine I, et al. . Plasmodium-specific atypical memory b cells are short-lived activated b cells. Elife (2018) 7:e39800. doi: 10.7554/eLife.39800</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.39800</ArticleId><ArticleId IdType="pmc">PMC6242553</ArticleId><ArticleId IdType="pubmed">30387712</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Diaz A, Romero M, Blomberg BB. Phenotypic and functional characterization of double negative b cells in the blood of individuals with obesity. Front Immunol (2021) 12:616650. doi: 10.3389/fimmu.2021.616650</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.616650</ArticleId><ArticleId IdType="pmc">PMC7940530</ArticleId><ArticleId IdType="pubmed">33708209</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin JW, Buckner CM, Kardava L, Wang W, Zhang X, Melson VA, et al. . Overexpression of T-bet in HIV infection is associated with accumulation of b cells outside germinal centers and poor affinity maturation. Sci Transl Med (2019) 11(520):eaax0904. doi: 10.1126/scitranslmed.aax0904</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax0904</ArticleId><ArticleId IdType="pmc">PMC7479651</ArticleId><ArticleId IdType="pubmed">31776286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricker E, Manni M, Flores-Castro D, Jenkins D, Gupta S, Rivera-Correa J, et al. . Altered function and differentiation of age-associated b cells contribute to the female bias in lupus mice. Nat Commun (2021) 12(1):4813. doi: 10.1038/s41467-021-25102-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25102-8</ArticleId><ArticleId IdType="pmc">PMC8355159</ArticleId><ArticleId IdType="pubmed">34376664</ArticleId></ArticleIdList></Reference><Reference><Citation>Manni M, Gupta S, Ricker E, Chinenov Y, Park SH, Shi M, et al. . Regulation of age-associated b cells by IRF5 in systemic autoimmunity. Nat Immunol (2018) 19(4):407&#x2013;19. doi: 10.1038/s41590-018-0056-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0056-8</ArticleId><ArticleId IdType="pmc">PMC6095139</ArticleId><ArticleId IdType="pubmed">29483597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Flores Castro D, Gupta S, Phalke S, Manni M, Rivera-Correa J, et al. . IL-13R&#x3b1;1-Mediated signaling regulates age-Associated/Autoimmune b-cell expansion and lupus pathogenesis. Arthritis Rheumatol (2022) 74(9):1544&#x2013;1555. doi:&#xa0;10.1002/art.42146</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42146</ArticleId><ArticleId IdType="pmc">PMC9427689</ArticleId><ArticleId IdType="pubmed">35438841</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Antao OQ, Condiff E, Sanchez GM, Chernova I, Zembrzuski K, et al. . Development of tbet- and CD11c-expressing b cells in a viral infection requires T follicular helper cells outside of germinal centers. Immunity (2022) 55(2):290&#x2013;307.e5. doi: 10.1016/j.immuni.2022.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8965751</ArticleId><ArticleId IdType="pubmed">35090581</ArticleId></ArticleIdList></Reference><Reference><Citation>Levack RC, Newell KL, Cabrera-Martinez B, Cox J, Perl A, Bastacky SI, et al. . Adenosine receptor 2a agonists target mouse CD11c(+)T-bet(+) b cells in infection and autoimmunity. Nat Commun (2022) 13(1):452. doi: 10.1038/s41467-022-28086-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28086-1</ArticleId><ArticleId IdType="pmc">PMC8782827</ArticleId><ArticleId IdType="pubmed">35064115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer J, Dirks J, Klaussner J, Haase G, Holl-Wieden A, Hofmann C, et al. . Effect of clonally expanded PD-1(high) CXCR5-CD4+ peripheral T helper cells on b cell differentiation in the joints of patients with antinuclear antibody-positive juvenile idiopathic arthritis. Arthritis Rheumatol (2022) 74(1):150&#x2013;62. doi: 10.1002/art.41913</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41913</ArticleId><ArticleId IdType="pubmed">34196496</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustini F, Sippl N, St&#xe5;lesen R, Chemin K, Dunn N, Fogdell-Hahn A, et al. . Rituximab in systemic lupus erythematosus: Transient effects on autoimmunity associated lymphocyte phenotypes and implications for immunogenicity. Front Immunol (2022) 13:826152. doi: 10.3389/fimmu.2022.826152</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.826152</ArticleId><ArticleId IdType="pmc">PMC9027571</ArticleId><ArticleId IdType="pubmed">35464461</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, et al. . IFNgamma induces epigenetic programming of human T-bet(hi) b cells and promotes TLR7/8 and IL-21 induced differentiation. Elife (2019) 8:e41641. doi: 10.7554/eLife.41641</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41641</ArticleId><ArticleId IdType="pmc">PMC6544433</ArticleId><ArticleId IdType="pubmed">31090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B, Strohmeier V, Harder I, Unger S, Payne KJ, Andrieux G, et al. . The expansion of human T-bet(high)CD21(low) b cells is T cell dependent. Sci Immunol (2021) 6(64):eabh0891. doi: 10.1126/sciimmunol.abh0891</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh0891</ArticleId><ArticleId IdType="pubmed">34623902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouat IC, Goldberg E, Horwitz MS. Age-associated b cells in autoimmune diseases. Cell Mol Life Sci (2022) 79(8):402. doi: 10.1007/s00018-022-04433-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04433-9</ArticleId><ArticleId IdType="pmc">PMC9263041</ArticleId><ArticleId IdType="pubmed">35798993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouat IC, Horwitz MS. Age-associated b cells in viral infection. PloS Pathog (2022) 18(3):e1010297. doi: 10.1371/journal.ppat.1010297</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010297</ArticleId><ArticleId IdType="pmc">PMC8929649</ArticleId><ArticleId IdType="pubmed">35298565</ArticleId></ArticleIdList></Reference><Reference><Citation>Phalke S, Rivera-Correa J, Jenkins D, Flores Castro D, Giannopoulou E, Pernis AB. Molecular mechanisms controlling age-associated b cells in autoimmunity. Immunol Rev (2022) 307(1):79&#x2013;100. doi: 10.1111/imr.13068</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13068</ArticleId><ArticleId IdType="pubmed">35102602</ArticleId></ArticleIdList></Reference><Reference><Citation>Du SW, Arkatkar T, Al Qureshah F, Jacobs HM, Thouvenel CD, Chiang K, et al. . Functional characterization of CD11c(+) age-associated b cells as memory b cells. J Immunol (2019) 203(11):2817&#x2013;26. doi: 10.4049/jimmunol.1900404</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900404</ArticleId><ArticleId IdType="pmc">PMC6864310</ArticleId><ArticleId IdType="pubmed">31636237</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell Knode LM, Naradikian MS, Myles A, Scholz JL, Hao Y, Liu D, et al. . Age-associated b cells express a diverse repertoire of V(H) and v&#x3ba; genes with somatic hypermutation. J Immunol (2017) 198(5):1921&#x2013;7. doi: 10.4049/jimmunol.1601106</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601106</ArticleId><ArticleId IdType="pmc">PMC5322232</ArticleId><ArticleId IdType="pubmed">28093524</ArticleId></ArticleIdList></Reference><Reference><Citation>Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, et al. . Cutting edge: IL-4, IL-21, and IFN-&#x3b3; interact to govern T-bet and CD11c expression in TLR-activated b cells. J Immunol (2016) 197(4):1023&#x2013;8. doi: 10.4049/jimmunol.1600522</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600522</ArticleId><ArticleId IdType="pmc">PMC4975960</ArticleId><ArticleId IdType="pubmed">27430719</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GJ, Canete PF, Wang H, Medhavy A, Bones J, Roco JA, et al. . TLR7 gain-of-function genetic variation causes human lupus. Nature (2022) 605(7909):349&#x2013;56. doi: 10.1038/s41586-022-04642-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Ohnishi N, Ni L, Akira S, Bacon KB. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in b cells. Nat Immunol (2003) 4(7):687&#x2013;93. doi: 10.1038/ni941</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni941</ArticleId><ArticleId IdType="pubmed">12766768</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;vesdi D, Angyal A, Huber K, Szili D, S&#xe1;rmay G. T-Bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades. Eur J Immunol (2014) 44(3):887&#x2013;93. doi: 10.1002/eji.201343841</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201343841</ArticleId><ArticleId IdType="pubmed">24249581</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Correa J, Guthmiller JJ, Vijay R, Fernandez-Arias C, Pardo-Ruge MA, Gonzalez S, et al. . Plasmodium DNA-mediated TLR9 activation of T-bet(+) b cells contributes to autoimmune anaemia during malaria. Nat Commun (2017) 8(1):1282. doi: 10.1038/s41467-017-01476-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01476-6</ArticleId><ArticleId IdType="pmc">PMC5670202</ArticleId><ArticleId IdType="pubmed">29101363</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillatreau S, Manfroi B, Dorner T. Toll-like receptor signalling in b cells during systemic lupus erythematosus. Nat Rev Rheumatol (2021) 17(2):98&#x2013;108. doi: 10.1038/s41584-020-00544-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00544-4</ArticleId><ArticleId IdType="pmc">PMC7747191</ArticleId><ArticleId IdType="pubmed">33339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SW, Jacobs HM, Arkatkar T, Dam EM, Scharping NE, Kolhatkar NS, et al. . B cell IFN-gamma receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med (2016) 213(5):733&#x2013;50. doi: 10.1084/jem.20151724</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151724</ArticleId><ArticleId IdType="pmc">PMC4854732</ArticleId><ArticleId IdType="pubmed">27069113</ArticleId></ArticleIdList></Reference><Reference><Citation>Domeier PP, Chodisetti SB, Soni C, Schell SL, Elias MJ, Wong EB, et al. . IFN-gamma receptor and STAT1 signaling in b cells are central to spontaneous germinal center formation and autoimmunity. J Exp Med (2016) 213(5):715&#x2013;32. doi: 10.1084/jem.20151722</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151722</ArticleId><ArticleId IdType="pmc">PMC4854731</ArticleId><ArticleId IdType="pubmed">27069112</ArticleId></ArticleIdList></Reference><Reference><Citation>Levack RC, Newell KL, Popescu M, Cabrera-Martinez B, Winslow GM. CD11c(+) T-bet(+) b cells require IL-21 and IFN-&#x3b3; from type 1 T follicular helper cells and intrinsic bcl-6 expression but develop normally in the absence of T-bet. J Immunol (2020) 205(4):1050&#x2013;8. doi: 10.4049/jimmunol.2000206</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000206</ArticleId><ArticleId IdType="pmc">PMC7556359</ArticleId><ArticleId IdType="pubmed">32680956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. . The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun (2017) 8(1):254. doi: 10.1038/s41467-017-00348-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00348-3</ArticleId><ArticleId IdType="pmc">PMC5557982</ArticleId><ArticleId IdType="pubmed">28811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rincon-Arevalo H, Rojas M, Vanegas-Garcia A, Munoz-Vahos C, Orejuela-Erazo J, Vasquez G, et al. . Atypical phenotype and response of b cells in patients with seropositive rheumatoid arthritis. Clin Exp Immunol (2021) 204(2):221&#x2013;38. doi: 10.1111/cei.13576</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13576</ArticleId><ArticleId IdType="pmc">PMC8062998</ArticleId><ArticleId IdType="pubmed">33459349</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao W, Xie M, Ye Y. Age-associated b cells indicate disease activity in rheumatoid arthritis. Cell Immunol (2022) 377:104533. doi: 10.1016/j.cellimm.2022.104533</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2022.104533</ArticleId><ArticleId IdType="pubmed">35594728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbrink R, Spoorenberg A, Arends S, van der Geest KSM, Brouwer E, Bootsma H, et al. . CD27(-)CD38(low)CD21(low) b-cells are increased in axial spondyloarthritis. Front Immunol (2021) 12:686273. doi: 10.3389/fimmu.2021.686273</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686273</ArticleId><ArticleId IdType="pmc">PMC8217653</ArticleId><ArticleId IdType="pubmed">34168654</ArticleId></ArticleIdList></Reference><Reference><Citation>Couloume L, Ferrant J, Le Gallou S, Mandon M, Jean R, Bescher N, et al. . Mass cytometry identifies expansion of T-bet(+) b cells and CD206(+) monocytes in early multiple sclerosis. Front Immunol (2021) 12:653577. doi: 10.3389/fimmu.2021.653577</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.653577</ArticleId><ArticleId IdType="pmc">PMC8129576</ArticleId><ArticleId IdType="pubmed">34017332</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouat IC, Morse ZJ, Shanina I, Brown KL, Horwitz MS. Latent gammaherpesvirus exacerbates arthritis through modification of age-associated b cells. Elife (2021) 10:e67024. doi: 10.7554/eLife.67024</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67024</ArticleId><ArticleId IdType="pmc">PMC8337075</ArticleId><ArticleId IdType="pubmed">34080972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. . Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) b-cell population is important for the development of autoimmunity. Blood (2011) 118(5):1305&#x2013;15. doi: 10.1182/blood-2011-01-331462</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Qi Y, Li R, Shi Q, Satpathy AT, Chang HY. B cell-specific XIST complex enforces X-inactivation and restrains atypical b cells. Cell (2021) 184(7):1790&#x2013;803 e17. doi: 10.1016/j.cell.2021.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.015</ArticleId><ArticleId IdType="pmc">PMC9196326</ArticleId><ArticleId IdType="pubmed">33735607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Li Q, Zhou S, Zhao M, Lu L, Wu H, et al. . A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated b cells. J Autoimmun (2021) 123:102686. doi: 10.1016/j.jaut.2021.102686</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102686</ArticleId><ArticleId IdType="pubmed">34325305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratliff M, Alter S, Frasca D, Blomberg BB, Riley RL. In senescence, age-associated b cells secrete TNF&#x3b1; and inhibit survival of b-cell precursors. Aging Cell (2013) 12(2):303&#x2013;11. doi: 10.1111/acel.12055</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12055</ArticleId><ArticleId IdType="pmc">PMC3716274</ArticleId><ArticleId IdType="pubmed">23410004</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Romero M, Garcia D, Diaz A, Blomberg BB. Hyper-metabolic b cells in the spleens of old mice make antibodies with autoimmune specificities. Immun Ageing (2021) 18(1):9. doi: 10.1186/s12979-021-00222-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-021-00222-3</ArticleId><ArticleId IdType="pmc">PMC7916295</ArticleId><ArticleId IdType="pubmed">33639971</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber K, Sarmay G, Kovesdi D. MZ b cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10. Eur J Immunol (2016) 46(9):2239&#x2013;46. doi: 10.1002/eji.201546248</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201546248</ArticleId><ArticleId IdType="pubmed">27343199</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Cancro MP, Marrack P. Age-associated b cells: A T-bet-Dependent effector with roles in protective and pathogenic immunity. J Immunol (2015) 195(5):1933&#x2013;7. doi: 10.4049/jimmunol.1501209</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501209</ArticleId><ArticleId IdType="pmc">PMC4548292</ArticleId><ArticleId IdType="pubmed">26297793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicka W, Burakowski T, Warnawin E, Jastrzebska M, Bik M, Kontny E, et al. . Functional TLR9 modulates bone marrow b cells from rheumatoid arthritis patients. Eur J Immunol (2009) 39(5):1211&#x2013;20. doi: 10.1002/eji.200838617</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200838617</ArticleId><ArticleId IdType="pubmed">19384869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P. CD11c-expressing b cells are located at the T Cell/B cell border in spleen and are potent APCs. J Immunol (2015) 195(1):71&#x2013;9. doi: 10.4049/jimmunol.1500055</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500055</ArticleId><ArticleId IdType="pmc">PMC4475418</ArticleId><ArticleId IdType="pubmed">26034175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Thurman JM, Mennona JM, Kappler JW, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest (2017) 127(4):1392&#x2013;404. doi: 10.1172/JCI91250</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI91250</ArticleId><ArticleId IdType="pmc">PMC5373868</ArticleId><ArticleId IdType="pubmed">28240602</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of b cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. (1996) 93(1):221&#x2013;5. doi: 10.1073/pnas.93.1.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.1.221</ArticleId><ArticleId IdType="pmc">PMC40210</ArticleId><ArticleId IdType="pubmed">8552609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechanet J, Merville P, Durand I, Banchereau J, Miossec P. The ability of synoviocytes to support terminal differentiation of activated b cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest (1995) 95(2):456&#x2013;63. doi: 10.1172/JCI117685</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI117685</ArticleId><ArticleId IdType="pmc">PMC295488</ArticleId><ArticleId IdType="pubmed">7532184</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ. Fibroblast-like synoviocytes support b-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J Clin Invest (2001) 107(3):305&#x2013;15. doi: 10.1172/JCI11092</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI11092</ArticleId><ArticleId IdType="pmc">PMC199194</ArticleId><ArticleId IdType="pubmed">11160154</ArticleId></ArticleIdList></Reference><Reference><Citation>Armas-Gonzalez E, Dominguez-Luis MJ, Diaz-Martin A, Arce-Franco M, Castro-Hernandez J, Danelon G, et al. . Role of CXCL13 and CCL20 in the recruitment of b cells to inflammatory foci in chronic arthritis. Arthritis Res Ther (2018) 20(1):114. doi: 10.1186/s13075-018-1611-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1611-2</ArticleId><ArticleId IdType="pmc">PMC5992813</ArticleId><ArticleId IdType="pubmed">29880013</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SS, Moon EY. B cell adhesion to fibroblast-like synoviocytes is up-regulated by tumor necrosis factor-alpha via expression of human vascular cell adhesion molecule-1 mediated by b cell-activating factor. Int J Mol Sci (2021) 22(13):7166. doi: 10.3390/ijms22137166</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137166</ArticleId><ArticleId IdType="pmc">PMC8267633</ArticleId><ArticleId IdType="pubmed">34281218</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt V, Hahn M, Kastele V, Wagner O, Wiendl M, Derer A, et al. . Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts. Eur J Immunol (2017) 47(12):2101&#x2013;12. doi: 10.1002/eji.201646788</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201646788</ArticleId><ArticleId IdType="pubmed">28857172</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey S, Derer A, Messbacher ME, Baeten DL, Bugatti S, Montecucco C, et al. . The novel cytokine interleukin-36&#x3b1; is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis (2013) 72(9):1569&#x2013;74. doi: 10.1136/annrheumdis-2012-202264</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202264</ArticleId><ArticleId IdType="pubmed">23268368</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet (2011) 377(9783):2138&#x2013;49. doi: 10.1016/S0140-6736(11)60244-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60244-4</ArticleId><ArticleId IdType="pubmed">21684384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J (2021) 19(1):135. doi: 10.1186/s12969-021-00629-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00629-8</ArticleId><ArticleId IdType="pmc">PMC8383464</ArticleId><ArticleId IdType="pubmed">34425842</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud SA, Binstadt BA. Autoantibodies in the pathogenesis, diagnosis, and prognosis of juvenile idiopathic arthritis. Front Immunol (2018) 9:3168. doi: 10.3389/fimmu.2018.03168</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03168</ArticleId><ArticleId IdType="pmc">PMC6339949</ArticleId><ArticleId IdType="pubmed">30693002</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbach H, Girschick HJ. Do b cells play a role in the pathogenesis of juvenile idiopathic arthritis? Autoimmunity (2009) 42(4):373&#x2013;5. doi: 10.1080/08916930902832306</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930902832306</ArticleId><ArticleId IdType="pubmed">19811305</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegering V, Girschick HJ, Morbach H. B-cell pathology in juvenile idiopathic arthritis. Arthritis (2010) 2010:759868. doi: 10.1155/2010/759868</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/759868</ArticleId><ArticleId IdType="pmc">PMC3199973</ArticleId><ArticleId IdType="pubmed">22076178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MGL, Rosser EC. B cells as a therapeutic target in paediatric rheumatic disease. Front Immunol (2019) 10:214. doi: 10.3389/fimmu.2019.00214</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00214</ArticleId><ArticleId IdType="pmc">PMC6382733</ArticleId><ArticleId IdType="pubmed">30837988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirks J, Fischer J, Haase G, Holl-Wieden A, Hofmann C, Girschick H, et al. . CD21(lo/-)CD27(-)IgM(-) double-negative b cells accumulate in the joints of patients with antinuclear antibody-positive juvenile idiopathic arthritis. Front Pediatr (2021) 9:635815. doi: 10.3389/fped.2021.635815</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.635815</ArticleId><ArticleId IdType="pmc">PMC8085394</ArticleId><ArticleId IdType="pubmed">33937147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsk&#xf6;ld D, Parodis I, Lakshmikanth T, Sippl N, Khademi M, Chen Y, et al. . B cell alterations during BAFF inhibition with belimumab in SLE. EBioMedicine (2019) 40:517&#x2013;27. doi: 10.1016/j.ebiom.2018.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.12.035</ArticleId><ArticleId IdType="pmc">PMC6412067</ArticleId><ArticleId IdType="pubmed">30593436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura K, Lin Y, Yamaguchi H, Sato W, Takewaki D, Minote M, et al. . Th1 - CD11c(+) b cell axis associated with response to plasmapheresis in multiple sclerosis. Ann Neurol (2021) 90(4):595&#x2013;611. doi: 10.1002/ana.26202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26202</ArticleId><ArticleId IdType="pmc">PMC9293420</ArticleId><ArticleId IdType="pubmed">34424567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal-Pedrola G, Naamane N, Cameron JA, Pratt AG, Mellor AL, Isaacs JD, et al. . Characterization of age-associated b cells in early drug-naive rheumatoid arthritis patients. Immunology (2022). doi: 10.1111/imm.13598</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13598</ArticleId><ArticleId IdType="pubmed">36281956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta A, Kini R, Ohta A, Subramanian M, Madasu M, Sitkovsky M. The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front Immunol (2012) 3:190. doi: 10.3389/fimmu.2012.00190</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00190</ArticleId><ArticleId IdType="pmc">PMC3389649</ArticleId><ArticleId IdType="pubmed">22783261</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiel SE, Yang JA, Jenkins MK, Mueller DL. Cutting edge: Adenosine A2a receptor signals inhibit germinal center T follicular helper cell differentiation during the primary response to vaccination. J Immunol (2017) 198(2):623&#x2013;8. doi: 10.4049/jimmunol.1601686</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601686</ArticleId><ArticleId IdType="pmc">PMC5225048</ArticleId><ArticleId IdType="pubmed">27986907</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiel SE, Kalekar LA, Zhang N, Blankespoor TW, Robinson LJ, Mueller DL. Adenosine 2a receptor signal blockade of murine autoimmune arthritis via inhibition of pathogenic germinal center-follicular helper T cells. Arthritis Rheumatol (2019) 71(5):773&#x2013;83. doi: 10.1002/art.40796</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40796</ArticleId><ArticleId IdType="pmc">PMC6483839</ArticleId><ArticleId IdType="pubmed">30516351</ArticleId></ArticleIdList></Reference><Reference><Citation>Morandi F, Horenstein AL, Chillemi A, Quarona V, Chiesa S, Imperatori A, et al. . CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation. J Immunol (2015) 195(3):965&#x2013;72. doi: 10.4049/jimmunol.1500591</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500591</ArticleId><ArticleId IdType="pubmed">26091716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravani A, Vincenzi F, Bortoluzzi A, Padovan M, Pasquini S, Gessi S, et al. . Role and function of A(2A) and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis. Int J Mol Sci (2017) 18(4):697. doi: 10.3390/ijms18040697</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18040697</ArticleId><ArticleId IdType="pmc">PMC5412283</ArticleId><ArticleId IdType="pubmed">28338619</ArticleId></ArticleIdList></Reference><Reference><Citation>Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, et al. . A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release. Arthritis Res Ther (2011) 13(6):R197. doi: 10.1186/ar3527</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3527</ArticleId><ArticleId IdType="pmc">PMC3334647</ArticleId><ArticleId IdType="pubmed">22146575</ArticleId></ArticleIdList></Reference><Reference><Citation>Winslow GM, Papillion AM, Kenderes KJ, Levack RC. CD11c+ T-bet+ memory b cells: Immune maintenance during chronic infection and inflammation? Cell Immunol (2017) 321:8&#x2013;17. doi: 10.1016/j.cellimm.2017.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2017.07.006</ArticleId><ArticleId IdType="pmc">PMC5732029</ArticleId><ArticleId IdType="pubmed">28838763</ArticleId></ArticleIdList></Reference><Reference><Citation>Hocevar S, Puddinu V, Haeni L, Petri-Fink A, Wagner J, Alvarez M, et al. . PEGylated gold nanoparticles target age-associated b cells in vivo. ACS Nano (2022) 16(11):18119&#x2013;32. doi: 10.1021/acsnano.2c04871</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.2c04871</ArticleId><ArticleId IdType="pmc">PMC9706664</ArticleId><ArticleId IdType="pubmed">36301574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>